Table 1 Baseline characteristics of the study population
Frequency no (%) | ||
|---|---|---|
Study Area | Buea | 87 (43.5 %) |
Limbe | 62 (31.0) | |
Kumba | 51 (25.5) | |
Total | 200 (100) | |
Gender | Male | 101 (50.5) |
Female | 99 (49.5) | |
Total | 200 (100) | |
Age group (years) mean = 38.04 ± 10.52 years | ||
21–30 | 55 (27.5) | |
31–40 | 76 (38.0) | |
41–50 | 43 (21.5) | |
≥51 | 26 (13.0) | |
Total | 200 (100) | |
Education level | No formal education | 12 (6.0) |
Primary | 87 (43.5) | |
Secondary | 74 (37.0) | |
Tertiary | 27 (13.0) | |
Total | 200 (100) | |
eGFR (ml/min/1.73 m2) | <60 | 16 (8.0) |
≥60 | 184 (92.0) | |
Total | 200 (100) | |
Treatment groups | HAART | 70 (35.0) |
DOTS | 70 (35.0) | |
HAART/ DOTS | 60 (30.0) | |
Total | 200 (100) | |
Type of HAART | AZT/3TC/NVP | 46 (65.7) |
1 HAART group (n = 70) | AZT/3TC/EVP | 3 (4.3) |
TNV/3TC/NVP | 21 (30.0) | |
2 HAART/DOTS group (n = 60) | AZT/3TC/NVP | 34 (56.7) |
AZT/3TC/EVP | 3 (5.0) | |
TNV/3TC/NVP | 23 (38.3) | |
Total | 130 (65) | |
Type of DOTS | ||
1 DOTS group (n = 70) | ||
RIF/INH/ETH/PZA | 38 (54.3) | |
RIF/INH | 32 (45.7) | |
2 HAART/DOTS group (n = 60) | RIF/INH/ETH/PZA | 25 (41.7) |
RIF/INH | 35 (58.3) | |
Total | 130 (65) |